CDER’s work with foreign stakeholders enables progress in the harmonization of scientific and technical standards and regulatory requirements among regulatory authorities.
Similar Posts
Navitas Organics Voluntarily Recalls Select Lots of 8oz Organic Chia Seeds Because of Possible Health Risk
Navitas Organics is voluntarily recalling select lots of its 8oz Organic Chia Seeds due to possible Salmonella contamination. This recall is being conducted as a precautionary measure following a recall initiated by the company’s chia seed supplier.CDER SBIA On-Demand Learning Library
FDA’s CDER Small Business and Industry Assistance (SBIA) is making available our YouTube learning library – now hundreds of our recordings are readily accessible.Wells Pharma of Houston, LLC – 713015 – 11/07/2025
Compounding Pharmacy/Adulterated Drug ProductsLEESAR, Inc. Fort Myers, FL. 483 issued 05/09/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 05/09/2025
Short Title (70 char) LEESAR, Inc. Fort Myers, FL. 483 issued 05/09/2025
FEI Number 3010166880
Firm Name LEESAR, Inc.
Record Type 483
State FL
Establishment Type Outsourcing FacilityPeterson Company Recalls Twin Sisters Creamery Brand Whatcom Blue and Farmhouse Cheese Products Because of Possible Health Risk
October 26, 2025, Peterson Company of Auburn, WA is voluntarily recalling Twin Sisters Creamery brand item# 28855 Whatcom Blue and item# 29608 Farmhouse Cheese products which were made from raw milk because they may be contaminated with Shiga toxin-producingFusion IV Pharmaceuticals Inc. dba Axia Pharmaceuticals, Los Angeles, CA. 483, Second Amended 483 Issued 03/23/2017
Task Description Request Please post to the 2017 Pharmacy Inspections and Related Records Web page
Record Date 03/23/2017
FEI Number 3013341563
Firm Name Fusion IV Pharmaceuticals Inc. dba Axia Pharmaceutical
Record Type 483
State CA
Establishment Type Producer of Sterile Drug Products